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Abstract
Adenocarcinoma arising from jejunal ectopic pancreas is very rare. We report a case of a 69-year-old female with
adenocarcinoma arising from jejunal ectopic pancreas after resection of advanced colon cancer. She underwent
right hemicolectomy for advanced ascending colon cancer (ypT3N0M0, stage IIA) after chemotherapy. Two and half
years after colectomy, her tumor markers were elevated, and computed tomography revealed a mass measuring
20 × 20 mm in the small intestine, having an abnormal uptake of 18F-fluorodeoxyglucose on 18F-fluorodeoxyglucose-
positron emission tomography (18FDG-PET). Double-balloon enteroscopy revealed a submucosal tumor in the jejunum,
and histopathology of biopsy specimens from that lesion showed ectopic pancreas without malignancy. Therefore,
peritoneal metastasis from colon cancer concomitant with ectopic pancreas or adenocarcinoma arising from ectopic
pancreas was considered as a differential diagnosis. She underwent laparoscopic jejunectomy. Pathological
examination revealed a moderately differentiated adenocarcinoma arising from jejunal ectopic pancreas, not
peritoneal metastasis from colon cancer. Even if histopathology of the biopsy specimen shows ectopic pancreas
without malignancy, adenocarcinoma arising from ectopic pancreas should be considered when the tumor
markers are elevated or the lesion has an abnormal uptake of 18FDG.
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Background
Ectopic pancreas is defined as pancreatic tissue lacking
anatomical and vascular continuity with the normally lo-
cated pancreas. Ectopic pancreas is usually an asymp-
tomatic, incidental finding at laparotomy or autopsy, and
its malignant transformation is extremely rare, especially
in persons with jejunal ectopic pancreas [1–3]. There-
fore, adenocarcinoma arising from ectopic pancreas is
difficult to diagnose before resection. The appropriate
extent of lymph node dissection, the effect of chemo-
therapy, and the prognosis remain unclear [4]. We
herein report a case of adenocarcinoma arising from je-
junal ectopic pancreas with peritoneal metastasis-like
features that occurred after resection of advanced colo-
rectal cancer.
Case presentation
A 65-year-old Japanese female underwent ileal-colonic
bypass for unresectable ascending colon cancer with in-
vasion to the duodenum and multiple pulmonary nod-
ules, suspected to be pulmonary metastases. She was a
current smoker and had no pertinent medical history.
After she received 37 cycles of chemotherapy combining
folinic acid, 5-fluorouracil, irinotecan, and bevacizumab
(FOLFIRI+Bev), computed tomography (CT) showed a
remarkable reduction in tumor size in the ascending
colon. The sizes of the patient’s pulmonary nodules were
not changed; hence, they were considered as benign lesions,
and the primary lesion was regarded as resectable. She
underwent right hemicolectomy with lymphadenectomy
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as conversion therapy. The specimen could be removed
without duodenectomy. Histopathologically, the tumor
was 35 × 34 mm, tub2, ly0, v2, ypT3, ypN0, classified as
stage IIA according to the Tumor Node Metastasis Classi-
fication of the International Union Against Cancer, ver-
sion 7.0 [5]. The patient maintained normal carbohydrate
antigen 19-9 (CA19-9) levels (<37 U/mL) and slightly high
carcinoembryonic antigen (CEA) levels at 10 ng/mL (nor-
mal, <5.0 ng/ml) after the colectomy. However, two and
half years after the colectomy, the serum CA19-9 level
and CEA level increased to 635 U/mL and 22 ng/mL,
respectively. CT revealed a mass measuring 20 × 20 mm
in the small intestine (Fig. 1a). 18F-fluorodeoxyglucose-
positron emission tomography/computed tomography
(18FDG-PET/CT) revealed an abnormal uptake of 18FDG
in that region, with maximum standardized uptake values
of 5.7 (Fig. 1b). Double-balloon enteroscopy revealed an
approximately 2-cm submucosal tumor in the jejunum at
100 cm from the incisor teeth. An irregular-shaped de-
pression with a reddish color change was noted at the oral
side of the lesion (Fig. 2). Histopathology of biopsy speci-
mens from that lesion showed ectopic pancreas without
malignancy. Therefore, peritoneal metastasis from colon
cancer concomitant with ectopic pancreas or adenocarcin-
oma arising from ectopic pancreas was considered as a
differential diagnosis. The patient underwent laparoscopic
jejunectomy (resection of the jejunum, 20 cm) with re-
gional lymph node dissection. Peritoneal metastasis was
not observed. The patient’s postoperative course was un-
eventful. Gross examination revealed a rubbery mass
measuring 28 × 20 mm, which had invaded the serosal
surface of the jejunum. The cut surface of the tumor had
a yellowish-white mass in the jejunal wall.
The findings of histopathological examination were as
follows: ectopic pancreatic tissue was detected below the
mucosal layer, and consisted of acini and ducts, without
Langerhans cells (Fig. 3a); moderately differentiated
adenocarcinomas proliferated diffusely in an area ran-
ging from the submucosal layer to the serosa (Fig. 3b, c);
and they were also found in the epithelium of the ducts
(Fig. 3d). This type of adenocarcinoma (Fig. 4a) was
completely different from the previously resected colon
cancer (Fig. 4b). Immunohistochemistry analysis was
positive for cytokeratin 7 (CK7), mucin 1 (MUC1), and
MUC5AC and negative for CK20, caudal-related homeo-
box gene 2 (CDX-2), and MUC6. These findings resulted
in a diagnosis of adenocarcinoma arising from ectopic
pancreas. A single lymph node located close to the
tumor was found to be metastatic.
One month after surgery, the CA19-9 level decreased
to normal, and an oral fluoropyrimidine derivative (S-1)
started to be administrated as adjuvant chemotherapy,
according to the protocol for treatment of resected pan-
creatic cancer [6]. However, the patient discontinued the
chemotherapy because of adverse effects after receiving
2 cycles. Nine months after surgery, the serum CA19-9
level and CEA level increased to 273 U/mL and 28 ng/mL,
respectively, and CT revealed multiple nodules in the ab-
domen with abnormal uptakes of 18FDG. Biopsy of these
lesions was recommended to the patient; however, she
rejected it. Peritoneal metastasis from ectopic pancreatic
adenocarcinoma was suspected rather than peritoneal me-
tastasis from colon cancer because the serum CA19-9
level was almost normal before treatment of colon cancer
was begun (Fig. 5). Therefore, gemcitabine and nab pacli-
taxel were administrated for recurrent pancreatic cancer.
After receiving 3 cycles, she maintained stable disease.
Discussion
Ectopic pancreas is the presence of pancreatic tissue
located outside the normal pancreas. It is observed in
0.5 % of upper abdominal laparotomies and 0.6 to
Fig. 1 Computed tomography showed a mass measuring 20 × 20 mm in the small intestine (a) (arrow), and 18F-fluorodeoxyglucose (18FDG)-positron
emission tomography/computed tomography showed an abnormal uptake of 18FDG in the lesion (b) (arrow)
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13.7 % of autopsy studies [1, 5]. It is preferentially
found in the upper gastrointestinal tract (stomach
26 % and duodenum 28 %), followed by the small
bowel (18 %), Meckel’s diverticulum (6 %), the colon,
spleen, and gallbladder [7, 8]. The Heinrich classifica-
tion is widely used for pathological classification of ec-
topic pancreas [9]. Heinrich type I contains ducts,
acini, and islets. Heinrich type II is composed of ducts
and acini, lacking islets. Heinrich type III consists of
ducts and smooth muscle tissue only, lacking acini and
islets. Our case lacked islets, so we classified the ec-
topic pancreas as Heinrich type II.
The incidence of malignant transformation of ectopic
pancreas has been reported to range from 0.7 to 1.8 %
[7, 8]. Moreover, ectopic pancreatic carcinoma is usually
located in the stomach or the duodenum; ectopic pan-
creas in the jejunum is extremely rare [3, 8]. Criteria
have been proposed for the diagnosis of carcinoma from
an ectopic pancreas as follows: (1) the tumor must be lo-
cated within or near the ectopic pancreas tissue, (2)
transition between pancreatic tissue and carcinoma must
be observed, and (3) the non-neoplastic pancreatic tissue
must comprise fully developed acini and ducts [7]. Our
case satisfied these three criteria. In immunohistochemi-
cal staining, CK7, MUC1, and MUC5AC were positive,
and CK20 and CDX-2 were negative, which is in good
agreement with the features of ordinary pancreatic
adenocarcinoma [8–10]. The histology of ectopic pan-
creatic adenocarcinoma was completely different from
the histology of colon cancer. Thus, these pathological
findings were consistent with a diagnosis of adenocarcin-
oma arising from jejunal ectopic pancreas, not with a
diagnosis of peritoneal metastasis from colon cancer.
In our case, the tumor markers, measured for surveil-
lance of recurrence after resection of advanced colon can-
cer, were elevated. CT revealed a mass with abnormal
Fig. 3 Histological findings of submucosal tumor. Pancreatic tissue consisting of acini and ducts was detected below the mucosal layer (a).
Moderately differentiated adenocarcinomas proliferated diffusely in an area ranging from the submucosal layer (b) to the serosa (c) and were also
found in the epithelium of the ducts (d)
Fig. 2 Double-balloon enteroscopy showed an approximately 2-cm
submucosal tumor in the jejunum at 100 cm from the incisor teeth
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uptake of 18FDG in that region in 18FDG-PET. First, peri-
toneal metastasis from colon cancer or primary small in-
testinal cancer was suspected. However, double-balloon
enteroscopy revealed a submucosal tumor in the jejunum,
and histopathology of the biopsy specimens showed ec-
topic pancreas without malignancy. On the basis of the
findings of elevated tumor marker and abnormal uptake
of 18FDG, peritoneal metastasis from colon cancer with
ectopic pancreas or adenocarcinoma arising from ectopic
pancreas was considered as a differential diagnosis; there-
fore, resection of that lesion was required.
We performed a PubMed search of the English litera-
ture from 1966 to 2014 using the following keywords:
ectopic, aberrant, heterotopic, pancreas, jejunum, small
intestine, adenocarcinoma, and cancer. We also retrieved
cases from the relevant reference lists. We found six
Fig. 5 Chronological changes of the serum levels of CA19-9 and CEA. FOLFIRI+Bev folinic acid, 5-fluorouracil, irinotecan, and bevacizumab; S-1 an
oral fluoropyrimidine derivative
Fig. 4 Microscopic view of resected submucosal tumor in the jejunum (a) was completely different from that of previously resected
colon cancer (b)
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1 1988 85 F Bowel obstruction ND ND 15 ND ND ND ND 11
2 1999 63 M Bowel obstruction 6100 17 40 × 20 II ND ND ND (peritoneal carcinomatosis
and hepatic metastasis at surgery)
12
3 1999 61 M Bowel obstruction ND ND 15 I ND ND ND 13
4 2008 64 F Bowel obstruction ND ND 20 ND ND Gemcitabine Death (5 months) (peritoneal
carcinomatosis)
14
5 2010 76 F Bowel obstruction 76 Normal 20 × 15 III Positive ND Death (5 months) (hepatic
metastasis)
3
6 2012 74 M Diffuse peritonitis 88 Normal 30 II ND ND ND 15
Present
case
2015 69 F Elevation of tumor
marker
635 22 20 × 20 II Positive S-1 Not death (9 months)
(peritoneal carcinomatosis)
–
Normal levels of CA19-9 and CEA are below 37 U/mL and 5 ng/mL, respectively











previous reports of adenocarcinoma arising from jejunal
ectopic pancreas (Table 1) [3, 11–15]. Six cases other than
our case had abdominal symptoms. There were no cases
diagnosed as adenocarcinoma arising from ectopic pan-
creas preoperatively. The serum CA19-9 level was predom-
inantly elevated compared to the elevation of the serum
CEA level, which was consistent with ordinary pancreatic
cancer [16]. Lymph node metastasis was observed in two
cases. There has been no evidence of the efficacy of chemo-
therapy for adenocarcinoma arising from gastrointestinal
ectopic pancreas. Fukino et al. reported a case in which
gemcitabine was effective for recurrent adenocarcinoma
arising from duodenal ectopic pancreas [4]. The prognosis
of adenocarcinoma arising from ectopic pancreas is also
unclear. A few patients were reported to be alive without
recurrence more than 5 years after resection of adenocar-
cinoma arising from ectopic gastric or duodenal pancreas,
and reports have also indicated a more favorable prognosis
than that for ordinary pancreatic cancer because of its earl-
ier presentation [17–20]. However, in our literature review,
four patients with adenocarcinoma arising from jejunal
ectopic pancreas experienced distant metastasis, and sur-
vival time ranged from 5 to 9 months. As for adenocarcin-
oma arising from jejunal ectopic pancreas, the prognosis
seems to be worse than that for adenocarcinoma arising
from other gastrointestinal ectopic pancreases. This might
result from differences in lymph node dissection. For
adenocarcinoma arising from gastric or duodenal ectopic
pancreas, lymph node dissection is performed according to
the presence of gastric cancer or duodenal cancer. How-
ever, as for the small intestine, the efficacy and appropriate
extent of lymph node dissection are unknown. More cases
need to be investigated to provide some answers.
Conclusions
In summary, we report a rare case of adenocarcinoma
arising from jejunal ectopic pancreas after resection of
advanced colon cancer. Even if histopathology of the bi-
opsy specimen shows ectopic pancreas without malig-
nancy, adenocarcinoma arising from ectopic pancreas
should be considered when the tumor markers are ele-
vated or the lesion has an abnormal uptake of 18FDG.
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